JACQUES JM
VAN DONGEN
Investigador
University of Paris-Sorbonne
París, FranciaPublicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (9)
2022
-
Critical Implications of IVDR for Innovation in Diagnostics: Input from the BioMed Alliance Diagnostics Task Force
HemaSphere, Vol. 6, Núm. 6, pp. E724
2020
-
BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency
Journal of Clinical Immunology, Vol. 40, Núm. 1, pp. 138-146
2019
-
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
Leukemia, Vol. 33, Núm. 9, pp. 2254-2265
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia, Vol. 33, Núm. 9, pp. 2241-2253
2010
2007
-
Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL
Blood, Vol. 110, Núm. 1, pp. 388-392
-
Disseminated bacillus Calmette-Guérin infection and immunodeficiency [14]
Emerging Infectious Diseases
2005
-
CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes
Leukemia, Vol. 19, Núm. 11, pp. 1948-1957